Search

Author/Creator Espie, Pascal

1. Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non‐depleting anti‐CD40 monoclonal antibody. Issue 12 (24th May 2018)

Authors:
Ristov, Jacinda; Espie, Pascal; Ulrich, Peter; Sickert, Denise; Flandre, Thierry; Dimitrova, Mirela; Müller‐Ristig, Dorothee; Weider, Doris; Robert, Gautier; Schmutz, Patrick; Greutmann, Barbara; Cordoba‐Castro, Francisco; Schneider, Martin A.; Warncke, Max; Kolbinger, Frank; Cote, Serge; Heusser...
Journal:
American journal of transplantation
Issue:
Volume 18:Issue 12(2018)
Page Start:
2895
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. FRI0174 SUBCUTANEOUS DOSING OF THE NOVEL ANTI-CD40 ANTIBODY ISCALIMAB ACHIEVES TARGET DRUG EXPOSURE AND CLINICAL EFFICACY IN PRIMARY SJÖGREN'S SYNDROME; RESULTS OF A PHASE IIA RANDOMISED OPEN LABEL TWO ARM PARALLEL GROUP TRIAL. (June 2019)

Authors:
Fisher, Benjamin; Szántó, Antónia; Ng, Wan Fai; Bombardieri, Michele; Posch, Maximilian; Papas, Athena; Farag, Arwa; Daikeler, Thomas; Bannert, Bettina; Kivitz, Alan; Carsons, Steven; Isenberg, David; Barone, Francesca; Bowman, Simon J.; Espie, Pascal; Wieczorek, Grazyna; Moulin, Pierre; Floch, D...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
760
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PHASE 2 STUDY DESIGN EVALUATING EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY CFZ533 (ISCALIMAB) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: THE CONTRAIL I STUDY. Issue 3 (September 2020)

Authors:
Nashan, Björn; Knechtle, Stuart J.; Saliba, Faouzi; Laessing, Ute; Espie, Pascal; Klatt, Jan; Feng, Sandy
Journal:
Transplantation
Issue:
Volume 104:Issue 3(2020) Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗